Reports of abnormal cervical cancer screening tests in systemic sclerosis

Rheumatology

Volumn 48, Issue 2, 2009, Pages 149-151

  Bernatsky, Sasha ^a   Hudson, M ^a,b   Pope, J ^c   Markland, J ^d   Robinson, D ^e   Jones, N ^f   Docherty, P ^g   Abu Hakima, M ^h   Leclerc, S ^h   Dunne, J ⁱ   Smith, C D ^j   Sutton, E ^k   Khalidi, N ^l   Mathieu, J P ^m   Masetto, A ⁿ   Ligier, S ^m   Kaminska, E ^l   Baron, M ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g MONCTON HOSPITAL   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

^k DALHOUSIE UNIVERSITY   (Canada)

^l MCMASTER UNIVERSITY   (Canada)

^m UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁿ UNIVERSITÉ DE SHERBROOKE   (Canada)

more..

Author keywords

Cervical dysplasia; Malignancy; Pap test; Scleroderma; Systemic sclerosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PENICILLAMINE; TACROLIMUS;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CANADA; CANCER SCREENING; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SMOKING; SYSTEMIC SCLEROSIS; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

AGE OF ONSET; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LOGISTIC MODELS; ODDS RATIO; RISK FACTORS; SCLERODERMA, SYSTEMIC; SMOKING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 58749083234     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken442     Document Type: Article

References (20)

1. Derk CT, Rasheed M, Artlett CM, Jimenez SA. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006;33:1113-6.
2. Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28:1336-40.
3. Bernatsky S, Boivin J, Lawrence J et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005;52:1481-90.
4. Dhar JP, Kmak D, Bhan R, Pishorodi L, Ager J, Sokol RJ. Abnormal cervicovaginal cytology in women with lupus: A retrospective cohort study. Gynecol Oncol 2001;82:4-6.
5. Bernatsky S, Ramsey-Goldman R, Gordon C et al. Factors associated with abnormal Pap results in systemic lupus erythematosus. Rheumatology 2004;43: 1386-9.
6. Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med 2004;19:243-50.
7. Leroy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
8. Clements PJ, Lachenbruch PA, Seibold JR et al. Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
9. Sellors JW, Mahony JB, Kaczorowski J et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163:503-8.
10. Medsger TA Jr, Masi AT. The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. J Chronic Dis 1978;31:73-85.
11. Ferri C, Valentini G, Cozzi F et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 2002;81: 139-53.
12. Ognenovski VM, Marder W, Somers EC et al. Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol 2004;31:1763-7.
13. Wooten M. Systemic sclerosis and malignancy: A review of the literature. South Med J 2008;101:59-62.
14. Bernatsky SR, Cooper GS, Mill C, Ramsey-Goldman R, Clarke AE, Pineau CA. Cancer screening in patients with systemic lupus erythematosus. J Rheumatol 2006;33:45-9.
15. Newell S, Girgis A, Sanson-Fisher R, Ireland M. Accuracy of patients' recall of Pap and cholesterol screening. Am J Public Health 2000;90:1431-5.
16. ACOG practice bulletin. Cervical cytology screening. Int J Gynaecol Obstet 2003;83:237-47.
17. Tam LS, Chan AY, Chan PK, Chang AR, Li EK. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 2004;50:3619-25.
18. Nath R, Mant C, Luxton J et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 2007;57:619-25.
19. Bateman H, Yazici Y, Leff L, Peterson M, Paget SA. Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: A preliminary study. Lupus 2000;9:542-4.
20. Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001;10:394-400.